| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 08/16/2005 | US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products |
| 08/16/2005 | US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/11/2005 | WO2005073216A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005073195A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 08/11/2005 | WO2005072779A2 Growth factor-binding compounds attached to a calixarene |
| 08/11/2005 | WO2005051888A3 Diphenylamine derivatives |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050175543 Agents for magnetic imaging method |
| 08/11/2005 | CA2553674A1 Growth factor-binding compounds and methods of use |
| 08/11/2005 | CA2552317A1 Hcv ns-3 serine protease inhibitors |
| 08/10/2005 | EP1560574A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin |
| 08/10/2005 | EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 08/10/2005 | CN1653142A Coating composition comprising an acetal-functional binder |
| 08/10/2005 | CN1653037A Substituted tetracycline compounds |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652759A Small molecule entry inhibitors |
| 08/09/2005 | US6927303 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/09/2005 | CA2258217C Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 08/04/2005 | WO2005070878A1 Aromatic a-ring derivatives of tetracycline compounds |
| 08/04/2005 | WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/04/2005 | WO2005040355A3 Tao kinase modulators and methods of use |
| 08/04/2005 | US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/04/2005 | US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 08/04/2005 | US20050171148 Aryl and heteroaryl compounds, compositions, methods of use |
| 08/04/2005 | US20050171068 Novel 4-dedimethylaminotetracycline derivatives |
| 08/04/2005 | CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors |
| 08/03/2005 | EP1558568A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 08/03/2005 | EP1558567A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/03/2005 | CN1650163A Artificial receptors, building blocks, and methods |
| 08/03/2005 | CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1213038C Benzophenones as inhibitors of reverse transcriptase |
| 08/02/2005 | US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 08/02/2005 | US6924314 Compounds for the treatment of metabolic disorders |
| 08/02/2005 | CA2254972C Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 08/02/2005 | CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 07/28/2005 | WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/28/2005 | WO2005025554A3 Dipeptidyl peptidase iv inhibitor |
| 07/28/2005 | US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor |
| 07/28/2005 | US20050165069 Statine derivatives for the treatment of Alzheimer's disease |
| 07/28/2005 | US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla |
| 07/28/2005 | US20050164972 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | US20050164971 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 07/28/2005 | US20050164953 Beta-secretase inhibitors |
| 07/28/2005 | US20050164391 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 07/28/2005 | DE10361140A1 Verfahren zur Herstellung von dendritischen Trimesinsäuretriamiden A process for the preparation of dendritic Trimesinsäuretriamiden |
| 07/28/2005 | DE10360745A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 07/28/2005 | CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | CN1646091A Organosilicone derivatives of amino hydroxybenzophenones and their use as UV-A filters in cosmetic preparations |
| 07/26/2005 | CA2133439C Compounds useful for treating allergic and inflammatory diseases |
| 07/21/2005 | WO2005065315A2 Bone targeting compounds for delivering agents to the bone for interaction therewith |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159459 inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful to reduce forming beta peptides |
| 07/21/2005 | US20050159394 Aryl-substituted derivatives of cycloalkyl and branched chain alkyl carboxylic acids useful as antinociceptive drugs for peripheral targets |
| 07/21/2005 | CA2548849A1 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/20/2005 | EP1554242A1 Watersoluble prodrugs of propofol |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1173408B1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 07/20/2005 | CN1211351C Alpha-amino acid amides, prepn. thereof and the therapeutic use thereof |
| 07/19/2005 | US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives |
| 07/19/2005 | US6919339 ABCA-1 elevating compounds |
| 07/19/2005 | US6919324 Functionalized stilbene derivatives as improved vascular targeting agents |
| 07/14/2005 | WO2005063797A1 NONNATURAL C-LINKED CARBO-β-PEPTIDES WITH ROBUST SECONDARY STRUCTURES |
| 07/14/2005 | WO2005063689A1 Benzamide derivative |
| 07/14/2005 | WO2005063239A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/14/2005 | WO2005062874A2 Compounds and compositions for delivering active agents |
| 07/14/2005 | US20050154232 Nitrosation of the diphenylamine with an alkali metal nitrite in an acidic medium; the nitrosodiphenylamines increase the bioavailability of endothelial nitrogen monoxide; the diphenylamines are used as antioxidants and free radical scavengers; insulin resistance |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154061 peroxisome-proliferator-activated receptor (PPAR)-delta agonist; 2-[4-[[[2-[(2,4-Dichlorophenyl)amino]-2-oxoethyl]cyclohexylamino]methyl]-2-methylphenoxy]-2-methylpropanoic acid; cardiovascular disorders, dyslipidaemias or restenosis; improves HDL/LDL cholesterol ratio; side effect reduction |
| 07/14/2005 | US20050153944 Oxazole derivatives of tetracyclines |
| 07/14/2005 | CA2550649A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
| 07/13/2005 | EP1551795A1 Inhibitors of histone deacetylase |
| 07/13/2005 | EP1551793A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 07/13/2005 | EP1144364B1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636457A Fungicides for the control of take-all disease of plants |
| 07/13/2005 | CN1210251C Substituted nor bornylamion derivatives, method for production thereof, use thereof and medicaments containing said compounds |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916956 Calcium receptor antagonist |
| 07/12/2005 | US6916848 Compounds for the treatment of metabolic disorders |
| 07/12/2005 | US6916767 Antioxidant amines based on n-(4aniliophenyl) amides antioxidant amines based on n-(4-anilinophenyl) amides |
| 07/12/2005 | US6916489 Active agent transport systems |
| 07/12/2005 | US6916461 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 07/12/2005 | CA2201012C Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media |
| 07/07/2005 | WO2005061443A2 Benzoyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061437A2 Isopeptide gap junction modulators |
| 07/07/2005 | WO2005061434A1 Method for producing dendritic trimesic acid triamides |